Clorox Company (The)
CLX
Positions held
Your positionsCLX isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- Clorox operates in the essential household products sector, which tends to maintain steady demand even during economic downturns, providing a level of stability for investors.
- In Q2 2026, Clorox reported a revenue of $1.948 billion, a 17% increase compared to the prior quarter.
- The company has a dividend yield of 5.99%, indicating a commitment to returning value to shareholders.
- Clorox faces significant competition in the household products industry, which can pressure margins and market share.
- The company's earnings growth has declined by 50.1%, reflecting challenges in maintaining profitability.
- Clorox's operating margin has compressed to 12.6%, down from 17% in the previous quarter, indicating operational difficulties.
Fundamentals
| Market cap | $10.09B | Enterprise value | $15.71B | Trailing P/E | 17.35 | Forward P/E | 13.44 |
| PEG | 1.03 | Price / book | 112.15 | Beta | 0.57 | Dividend yield | 5.99% |
| Revenue growth | -2.0% | Earnings growth | -50.1% | Gross margin | 42.3% | Operating margin | 12.9% |
| Profit margin | 8.7% | ROE | 1.6% | ROA | 8.3% | Debt / equity | 22.21 |
| Current ratio | 0.66 | Free cash flow | $110.38M | Analyst recommendation | hold | Mean target | $99.59 |
| 52w high | $128.90 | 52w low | $79.12 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $1.9B | $1.7B | $1.7B | $1.4B | $2.0B | — |
| Op margin | 12.6% | 17.0% | 14.1% | 8.4% | 21.1% | — |
| Net income | $163M | $187M | $157M | $80.0M | $332M | — |
| Gross margin | 41.3% | 43.2% | 43.2% | 41.7% | 46.5% | — |
| Gross profit | $804M | $722M | $722M | $596M | $924M | — |
| Operating income | $246M | $284M | $236M | $120M | $420M | — |
- Revenue +17% vs prior quarter ($1.9B vs $1.7B).
- Gross margin 41.3% (was 43.2% prior quarter).
- Operating margin compressed to 12.6%.
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $6.7B | $7.1B | $7.1B | $7.4B | — |
| Op margin | 13.2% | 16.6% | 10.2% | 11.1% | — |
| Net income | $587M | $810M | $280M | $149M | — |
| Gross margin | 42.3% | 45.2% | 43.0% | 39.4% | — |
| Gross profit | $2.8B | $3.2B | $3.0B | $2.9B | — |
| Operating income | $886M | $1.2B | $723M | $823M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Evercore ISI Adjusts Price Target on Clorox Company to $99 From $110
2026-10-08 · Michael Burry Warns Anthropic’s Valuation Could Buy 78 Profitable S&P 500 Companies: ‘Fun Game in Times Like These’
2026-10-08 · Michael Burry Calls Anthropic's Valuation a Bubble Worth 78 S&P 500 Companies
2026-10-06 · How Investors Are Reacting To Clorox (CLX) Launching Its Unified Clorox Purell ProCare Health Platform
2026-10-06 · Anthropic Valuation At $965B Could Swallow Domino’s, Clorox, And 76 Other S&P 500 Firms, Burry Says
2026-10-06 · Colgate vs. Clorox: Which Consumer Staples Giant Holds the Edge?
2026-10-06 · Nscale Appoints Amy Banse to Board of Directors
2026-10-06 · Nscale Appoints Amy Banse to Board of Directors
2026-10-05 · The Clorox Company (CLX): Capitalizing on Volatility to Sell and Repurchase at New Lows
2026-10-05 · Goldman Sachs Adjusts Price Target on Clorox to $74 From $77, Maintains Sell Rating
Price (daily)
Full chart · RSI · MACD · patterns